Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashkan Emadi

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|October 19, 2016
Molecular Pathogenesis and Clinical Significance of Driver Mutations in Primary Myelofibrosis: A ReviewSalem H Alshemmari, Reshmi Rajan, Ashkan Emadi
Cancer Chemotherapy and Pharmacology|February 12, 2014
Asparaginase in the treatment of non-ALL hematologic malignanciesAshkan Emadi, Hania Zokaee, Edward A Sausville
Case Reports in Hematology|October 23, 2015
Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic LeukemiaSahar Mansoor, Noa G Holtzman, Ashkan Emadi
Cancer Biomarkers : Section a of Disease Markers|June 7, 2017
Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironmentsJennifer Ding, Judith E Karp, Ashkan Emadi
Cancer Chemotherapy and Pharmacology|November 26, 2014
Autophagy modulation: a target for cancer treatment developmentAlison Duffy, Jackson Le, Edward Sausville, et al.
Acta Haematologica|June 2, 2024
Biologic and Clinical Characteristics of Isochromosome der(17)(q10)t(15;17) in Acute Promyelocytic LeukemiaYuchen Liu, Yi Ning, Gabriel Ghiaur, et al.
Nature Reviews. Clinical Oncology|September 30, 2009
Cyclophosphamide and cancer: golden anniversaryAshkan Emadi, Richard J Jones, Robert A Brodsky
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Long-Term Follow up of Blinatumomab in Older Patients with B-Cell Acute Lymphoblastic LeukemiaYamini K Kathari, Max An, Christine Dougherty, et al.
Pharmaceuticals (Basel, Switzerland)|April 12, 2016
Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah's Witness with mutant IDH1/NPM1/NRAS Acute Myeloid LeukemiaAshkan Emadi, Najeebah A Bade, Brandi Stevenson, et al.
American Journal of Cancer Therapy and Pharmacology|November 9, 2018
The role of β-elimination for the clinical activity of hypomethylating agents and cyclophosphamide analoguesHaritha Reddy, Alison Duffy, Noa G Holtzman, et al.
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|October 19, 2016
Molecular Pathogenesis and Clinical Significance of Driver Mutations in Primary Myelofibrosis: A ReviewSalem H Alshemmari, Reshmi Rajan, Ashkan Emadi
Cancer Chemotherapy and Pharmacology|February 12, 2014
Asparaginase in the treatment of non-ALL hematologic malignanciesAshkan Emadi, Hania Zokaee, Edward A Sausville
Case Reports in Hematology|October 23, 2015
Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic LeukemiaSahar Mansoor, Noa G Holtzman, Ashkan Emadi
Cancer Biomarkers : Section a of Disease Markers|June 7, 2017
Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironmentsJennifer Ding, Judith E Karp, Ashkan Emadi
Cancer Chemotherapy and Pharmacology|November 26, 2014
Autophagy modulation: a target for cancer treatment developmentAlison Duffy, Jackson Le, Edward Sausville, et al.
Acta Haematologica|June 2, 2024
Biologic and Clinical Characteristics of Isochromosome der(17)(q10)t(15;17) in Acute Promyelocytic LeukemiaYuchen Liu, Yi Ning, Gabriel Ghiaur, et al.
Nature Reviews. Clinical Oncology|September 30, 2009
Cyclophosphamide and cancer: golden anniversaryAshkan Emadi, Richard J Jones, Robert A Brodsky
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Long-Term Follow up of Blinatumomab in Older Patients with B-Cell Acute Lymphoblastic LeukemiaYamini K Kathari, Max An, Christine Dougherty, et al.
Pharmaceuticals (Basel, Switzerland)|April 12, 2016
Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah's Witness with mutant IDH1/NPM1/NRAS Acute Myeloid LeukemiaAshkan Emadi, Najeebah A Bade, Brandi Stevenson, et al.
American Journal of Cancer Therapy and Pharmacology|November 9, 2018
The role of β-elimination for the clinical activity of hypomethylating agents and cyclophosphamide analoguesHaritha Reddy, Alison Duffy, Noa G Holtzman, et al.
Pageof 12